Apolipoprotein E4, Cholinergic Integrity, Synaptic Plasticity and Alzheimer’s Disease
Recent evidence indicates that apolipoprotein E (apoE) plays a central role in the hippocampal response to injury. The coordinated expression of apoE and its receptor, the apoE/apoB (LDL) receptor, appears to regulate the transport of cholesterol and phospholipids during the early and intermediate phases of the reinnervation process. During dendritic remodelling and synaptogenesis, neurons progressively repress the synthesis of cholesterol in favor of choles terol internalization through the apoE/LDL receptor pathway. The discovery that the apolipoprotein E4 allele is strongly linked to both sporadic and familial late onset Alzheimer’s disease (AD) raises the possibility that a dysfunction of the lipid transport system associated with compensatory sprouting and synaptic remodelling could be central to the AD process. The role of apoE in the central nervous system is particularly important in relation to the function of the cholinergic system, which relies to a certain extent on the integrity of phospholipid homeostasis in neurons. Recent evidence indicates that the apoE4 allele has a direct impact on cholinergic function and on cholinomimetic drug response in AD subjects.
KeywordsCholesterol Polypeptide Neurol Choline Acetylcholine
Unable to display preview. Download preview PDF.
- Beffert U, Poirier J (1995) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer’s disease. Ann NY Acad Sci, in pressGoogle Scholar
- Bertrand P, Oda T, Finch CE, Pasinetti GM, Poirier J (1995) Association between apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer’s disease. Mol Br Res, in pressGoogle Scholar
- Boyles JK, Zoellner CD, Anderson LJ, Kosick LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haeter PJ, Ignatius MJ, Shooter EM (1989) A role for apolipoprotein E, apolipoprotein A-l, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83: 1015–1031PubMedCrossRefGoogle Scholar
- Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NPV, Quirion R (1986) Nucleus basalis neuronal loss and choline acetyltransferase activity in advanced Alzheimer’s disease. Neuro-science 4: 1279–1291Google Scholar
- Guillaume D, Dea D, Davignon J, Poirier J (1995) Low density lipoprotein pathways in the central nervous system and apolipoprotein E isoform-specific differences. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski H (eds) Research advances in Alzheimer’s disease and related disorders. John Wiley and Sons, pp 384–395Google Scholar
- Masliah E, Mallory M, Alford M, Mucke L (1995) Abnormal synaptic regeneration in APP695 transgenic and apoE knockout mice. In: Iqbal K, Mortimer JA, Windblad B, Wisniewski HM (eds) Research advances in Alzheimer’s disease and related disorders. Wiley J and Sons, 405–414Google Scholar
- Poirier J, Aubert I, Bertrand P, Quirion R, Gauthier S, Nalbantoglu J (1994) Apolipoprotein E4 and cholinergic dysfunction in AD: a role for the amyloid/apoE4 complex? In: Giacobini E, Becker RE (eds) Alzheimer’s disease: therapeutic strategies. Birkhäuser, Boston, pp 72– 76Google Scholar
- Rail SC, Weisgraber KH, Mahley RW (1982) Abnormal lipoprotein receptor binding activity of the human apoE due to arginine-cysteine interchange at a single site. J Biol Chem 257: 4171– 4178Google Scholar
- Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid ß peptide: isoform-specific effect and implication for late onset Alzheimer’s disease. Proc Natl Acad Sci USA 90: 8098–8102PubMedCrossRefGoogle Scholar
- Tucek S (1978) Choline acetyltransferase. In: Acetylcholine synthesis in neurons. London, Chapman and Hall Ltd., pp 29–42Google Scholar